Nick Devoogdt (N Devoogdt)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Venues

International journal of molecular sciences

Cancers

Pharmaceuticals (Basel, Switzerland)

Molecular cancer therapeutics

Vrije Universiteit Brussel (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Vrije Universiteit Brussel Oct 01 1997 - May 10 2004

Belgium

PHD :: Cellular and Molecular Immunology

Vrije Universiteit Brussel Oct 01 1993 - Sep 15 1997

Belgium

MSC :: Cellular and Molecular Immunology

Publications

Heleen Hanssens, Fien Meeus, Emma L Gesquiere, Janik Puttemans, Yannick De De Vlaeminck, Kim De Veirman, Karine Breckpot, Nick Devoogdt
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties. International journal of molecular sciences 25 (11) (2024)
Heleen Hanssens, Fien Meeus, Emma L Gesquiere, Janik Puttemans, Yannick De De Vlaeminck, Kim De Veirman, Karine Breckpot, Nick Devoogdt
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties. International journal of molecular sciences 25 (11) (2024)
Ying Cong, Nick Devoogdt, Philippe Lambin, Ludwig J Dubois, Ala Yaromina
Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management. Cancers 16 (2) (2024)
Ying Cong, Nick Devoogdt, Philippe Lambin, Ludwig J Dubois, Ala Yaromina
Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management. Cancers 16 (2) (2024)
Timo W M De Groof, Yoline Lauwers, Tessa De Pauw, Mohit Saxena, Cécile Vincke, Jolien Van Craenenbroeck, Catherine Chapon, Roger Le Grand, Geert Raes, Thibaut Naninck, Jo A Van Ginderachter, Nick Devoogdt
Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β. European journal of nuclear medicine and molecular imaging (2024)
Heleen Hanssens, Fien Meeus, Emma L Gesquiere, Janik Puttemans, Yannick De De Vlaeminck, Kim De Veirman, Karine Breckpot, Nick Devoogdt
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties. International journal of molecular sciences 25 (11) (2024)
Tessa De Pauw, Lynn De Mey, Debacker Jens, Geert Raes, Jo A Van Ginderachter, Timo W M De Groof, Nick Devoogdt
Current status and future expectations of nanobodies in oncology trials. Expert opinion on investigational drugs (2023)
Cyprine Neba Funeh, Jessica Bridoux, Thomas Ertveldt, Timo W M De Groof, Dora Mugoli Chigoho, Parinaz Asiabi, Peter Covens, Matthias D'Huyvetter, Nick Devoogdt
Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy. Pharmaceutics 15 (5) (2023)
Neema Ahishakiye Jumapili, Maida Zivalj, Romina Mora Barthelmess, Geert Raes, Timo W M De Groof, Nick Devoogdt, Benoît Stijlemans, Cécile Vincke, Jo A Van Ginderachter
A few good reasons to use nanobodies for cancer treatment. European journal of immunology (2023)
Lan-Huong Tran, Geert-Jan Graulus, Cécile Vincke, Natalia Smiejkowska, Anne Kindt, Nick Devoogdt, Serge Muyldermans, Peter Adriaensens, Wanda J Guedens
Nanobodies for the Early Detection of Ovarian Cancer. International journal of molecular sciences 23 (22) (2022)
Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, Hanne Locy, Wout de Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De De Vlaeminck, Robin Maximilian Awad, Marleen Keyaerts, Nick Devoogdt, Matthias D'Huyvetter, Karine Breckpot, Ahmet Krasniqi
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model. Molecular cancer therapeutics 21 (7) (2022)
Pieterjan Debie, Noemi B Declerck, Danny van Willigen, Celine M Huygen, Bieke De Sloovere, Lukasz Mateusiak, Jessica Bridoux, Janik Puttemans, Nick Devoogdt, Fijs W B van Leeuwen, Sophie Hernot
The Design and Preclinical Evaluation of a Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery. Biomolecules 11 (3) (2021)
Cristina Barca, Christoph M Griessinger, Andreas Faust, Dominic Depke, Markus Essler, Albert D Windhorst, Nick Devoogdt, Kevin M Brindle, Michael Schäfers, Bastian Zinnhardt, Andreas H Jacobs
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Heleen Hanssens, Fien Meeus, Kim De Veirman, Karine Breckpot, Nick Devoogdt
The antigen-binding moiety in the driver's seat of CARs. Medicinal research reviews 42 (1) (2021)
Quentin Lecocq, Pieterjan Debie, Janik Puttemans, Robin Maximilian Awad, Lien De Beck, Thomas Ertveldt, Yannick De De Vlaeminck, Cleo Goyvaerts, Geert Raes, Marleen Keyaerts, Karine Breckpot, Nick Devoogdt
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer. EJNMMI research 11 (1) (2021)
Bert Schepens, Loes van Schie, Wim Nerinckx, Kenny Roose, Wander Van Breedam, Daria Fijalkowska, Simon Devos, Wannes Weyts, Sieglinde De Cae, Sandrine Vanmarcke, Chiara Lonigro, Hannah Eeckhaut, Dries Van Herpe, Jimmy Borloo, Ana Filipa Oliveira, João Paulo Portela Catani, Sarah Creytens, Dorien De Vlieger, Gitte Michielsen, Jackeline Cecilia Zavala Marchan, George D Moschonas, Iebe Rossey, Koen Sedeyn, Annelies Van Hecke, Xin Zhang, Lana Langendries, Sofie Jacobs, Sebastiaan Ter Horst, Laura Seldeslachts, Laurens Liesenborghs, Robbert Boudewijns, Hendrik-Jan Thibaut, Kai Dallmeier, Greetje Vande Velde, Birgit Weynand, Julius Beer, Daniel Schnepf, Annette Ohnemus, Isabel Remory, Shi-Yan Caroline Foo, Rana Abdelnabi, Piet Maes, Suzanne J F Kaptein, Joana Rocha-Pereira, Dirk Jochmans, Leen Delang, Frank Peelman, Peter Staeheli, Martin Schwemmle, Nick Devoogdt, Dominique Tersago, Massimiliano Germani, James T Heads, Alistair J Henry, Andrew Popplewell, Mark Ellis, Kevin Brady, Alison Turner, Bruno Dombrecht, Catelijne Stortelers, Johan Neyts, Nico Callewaert, Xavier Saelens
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models. Science translational medicine 13 (621) (2021)
Raf Van Campenhout, Serge Muyldermans, Mathieu Vinken, Nick Devoogdt, Timo W M De Groof
Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor. Biomolecules 11 (1) (2021)
Raf Van Campenhout, Ana Rita Gomes, Timo W M De Groof, Serge Muyldermans, Nick Devoogdt, Mathieu Vinken
Mechanisms Underlying Connexin Hemichannel Activation in Disease. International journal of molecular sciences 22 (7) (2021)
Dora Mugoli Chigoho, Quentin Lecocq, Robin Maximilian Awad, Karine Breckpot, Nick Devoogdt, Marleen Keyaerts, Vicky Caveliers, Catarina Xavier, Jessica Bridoux
Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide-Cysteine Chemistry. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans, Karel Fostier, Pieterjan Debie, Heleen Hanssens, Magdalena Rodak, Marek Pruszynski, Kim De Veirman, Karin Vanderkerken, Tony Lahoutte, Alfred Morgenstern, Frank Bruchertseifer, Nick Devoogdt, Matthias D'Huyvetter
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy. Molecular cancer therapeutics (2021)
Janik Puttemans, Yana Dekempeneer, Jos L Eersels, Heleen Hanssens, Pieterjan Debie, Marleen Keyaerts, Albert D Windhorst, Frank van der Aa, Quentin Lecocq, Karine Breckpot, Alfred Morgenstern, Frank Bruchertseifer, Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter
Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies. Cancers 12 (4) (2020)
Ema Romão, Ahmet Krasniqi, Laila Maes, Camille Vandenbrande, Yann G-J Sterckx, Benoit Stijlemans, Cécile Vincke, Nick Devoogdt, Serge Muyldermans
Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33. International journal of molecular sciences 21 (1) (2020)
Jessica Bridoux, Sara Neyt, Pieterjan Debie, Benedicte Descamps, Nick Devoogdt, Frederik Cleeren, Guy Bormans, Alexis Broisat, Vicky Caveliers, Catarina Xavier, Christian Vanhove, Sophie Hernot
Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging. Molecules (Basel, Switzerland) 25 (8) (2020)
Quentin Lecocq, Marleen Keyaerts, Nick Devoogdt, Karine Breckpot
The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm. International journal of molecular sciences 22 (1) (2020)
Frederik Cleeren, Joan Lecina, Jessica Bridoux, Nick Devoogdt, Térence Tshibangu, Catarina Xavier, Guy Bormans
Direct fluorine-18 labeling of heat-sensitive biomolecules for positron emission tomography imaging using the Al18F-RESCA method. Nature protocols 13 (10) (2019)
Pieterjan Debie, Nick Devoogdt, Sophie Hernot
Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery. Antibodies (Basel, Switzerland) 8 (1) (2019)

Nick Devoogdt.css-eqlu8i{font-size:small;padding-left:4px;} (N Devoogdt)

Publication Activity (10 Years)

Top Topics

Top Venues

Nick Devoogdt (N Devoogdt)